Month: March 2023

iBio Advances Anti-CCR8 Antibody Program to Preclinical In Vivo Testing

Written by Customer Service on March 31, 2023. Posted in Public Companies.

– Immuno-oncology candidate discovered using iBio’s AI epitope steering platform – – Expands Treg depletion franchise beyond IBIO-101 – BRYAN, Texas, March 31, 2023 (GLOBE NEWSWIRE) — iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody immunotherapies, today announced the progression of its anti-CCR8 antibody immuno-oncology program into preclinical in vivo testing. CCR8, a member of the G protein-coupled receptor (“GPCR”) family, is expressed by T-regulatory cells (“Tregs”) that play a crucial role in inducing immunosuppression across various cancer types. GPCRs are one of the most successful therapeutic target classes, with approximately one-third of all approved drugs targeting these proteins.1 Compared to small molecule-based GPCR drugs, antibody-based GPCR therapeutics potentially...

Adyton Resources Corporation Grants Restricted Shares

Written by Customer Service on March 31, 2023. Posted in Public Companies.

About Adyton For more information about Adyton, visit www.adytonresources.comPORT MORESBY, Papua New Guinea, March 31, 2023 (GLOBE NEWSWIRE) — Adyton Resources Corporation (TSX Venture: ADY) (“Adyton” or the “Company”) announces that it has granted an aggregate of 4,182,999 restricted shares to its officers, directors and certain consultants pursuant to the Company’s Non-Option Omnibus Incentive Plan and as compensation for ongoing services rendered to the Company. The restricted shares will vest in three equal tranches on each of four, eight and twelve months after the grant date. The restricted shares are subject to trading restrictions and a repurchase right by the Company until they have vested. ON BEHALF OF THE BOARD OF ADYTON RESOURCES CORPORATION Tim Crossley, Chief Executive Officer For further information please contact: Tim...

Fintech and Agri-Fintech Company, Tingo Group, Inc., Reports Full Year 2022 Financial Results

Written by Customer Service on March 31, 2023. Posted in Earnings Releases And Operating Results.

Acquisition of 100% of Tingo Mobile Completed on November 30, 2022, making the Company significantly profitable from December 1, 2022 Company’s Integration with Tingo Mobile saw a Significant Acceleration in Growth of the Combined Group During Q4 2022, with the Signing of Major New Trade Partnerships, International Expansion and Launch of Several Significant New Products and Businesses Acquisition of Tingo Foods Plc Completed on February 7, 2023 Name Change to Tingo Group, Inc. Reflects Importance of Tingo Brand and the Company’s Focus on Leveraging its Significant Market Presence MONTVALE, N.J., March 31, 2023 (GLOBE NEWSWIRE) — Tingo Group, Inc. (NASDAQ: TIO) (“Tingo” or the “Company”) today announced its financial results for the fiscal year ended December 31, 2022. The acquisition of 100% of Tingo Mobile Limited (“Tingo Mobile”),...

Bioventus Reports Fourth Quarter and Full-Year 2022 Financial Results

Written by Customer Service on March 31, 2023. Posted in Earnings Releases And Operating Results.

DURHAM, N.C., March 31, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or “the Company”), a global leader in innovations for active healing, today reported financial results for the year ended December 31, 2022. Q4 Financial Summary & Recent Highlights:Net Sales of $125.8 million, down $4.6 million, or (3.5%), year-over-year as reported ((2.9%) constant currency* and down (9.5%) organically* (9.0%) constant currency*) Net Loss of $44.9 million, compared to Net Loss of $1.9 million in prior-year period Adjusted EBITDA* of $15.2 million, compared to $28.5 million in prior-year period Loss per share of Class A common stock of $0.52, compared to $0.01 in prior-year period Non-GAAP loss per share* of $0.06, compared to Non-GAAP earnings per share of $0.26 in prior-year periodFY 2022...

Cybersecurity Solutions Provider BIO-key’s 2022 Revenues Increased 37% to $7.0M Reflecting Growing Base of Annual Recurring Revenue; Investor Call Today at 10am ET

Written by Customer Service on March 31, 2023. Posted in Earnings Releases And Operating Results.

Expects record quarterly revenue in Q1 2023 WALL, N.J., March 31, 2023 (GLOBE NEWSWIRE) — BIO-key®International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access management (IAM) and Identity-Bound Biometric (IBB) solutions, today reported results for its fourth quarter (Q4’22) and year ended December 31, 2022 (FY’22). BIO-key will host an investor call today at 10:00 a.m. ET (details below) to review its results and outlook. Highlights:Q4’22 revenues grew 88% to $1.7M and FY’22 revenues increased 37% to $7.0M, reflecting increasing software and services revenues, partially offset by lower hardware revenue in both periods. Continued strength in higher education franchise, including recent IAM deployments with the University of Georgia’s Abraham Baldwin Agricultural College; National Louis...

Instil Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Written by Customer Service on March 31, 2023. Posted in Earnings Releases And Operating Results.

Instil confirms cash runway beyond 2026 ITIL-306 phase 1 study anticipated to receive CTA clearance from UK MHRA in 2H’2023 Anticipate initial clinical data from ITIL-306 phase 1 program in 2024 DALLAS, March 31, 2023 (GLOBE NEWSWIRE) — Instil Bio, Inc. (“Instil”) (NASDAQ: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer, today reported its fourth quarter and full-year 2022 financial results and provided a corporate update. Fourth Quarter 2022 Highlights and Anticipated Milestones:Instil confirms cash runway beyond 2026 with consolidation of R&D operations to the UK: In January 2023, the Company announced the consolidation of the Phase 1 clinical trial and related manufacturing of CoStAR-TIL™ to its...

VAALCO Energy, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Results and Provides 2023 Guidance

Written by Customer Service on March 31, 2023. Posted in Earnings Releases And Operating Results.

Increased Year-End 2022 Sec Proved Reserves by 149% to 27.9 MMBOE With PV-10 Value Up 529% to $624 Million HOUSTON, March 31, 2023 (GLOBE NEWSWIRE) — VAALCO Energy, Inc. (NYSE: EGY, LSE: EGY) (“VAALCO” or the “Company”) today reported operational and selected preliminary unaudited financial results for the fourth quarter and full year of 2022. On October 13, 2022, VAALCO completed the business combination with TransGlobe Energy, Inc. (“TransGlobe”); as a result, VAALCO’s fourth quarter and full year preliminary 2022 results include the combined assets from the closing day through the end of 2022. The financial data presented in this press release for the fourth quarter and year ended December 31, 2022 is preliminary and subject to change in connection with the completion and audit of VAALCO’s financial statements...

Lithium Americas Reports 2022 Full Year and Fourth Quarter Results

Written by Customer Service on March 31, 2023. Posted in Public Companies.

VANCOUVER, British Columbia, March 31, 2023 (GLOBE NEWSWIRE) — Lithium Americas Corp. (TSX: LAC) (NYSE: LAC) (“Lithium Americas” or the “Company”) has reported financial and operating results for the fourth quarter and year ended December 31, 2022. HIGHLIGHTS Argentina Caucharí-OlarozConstruction is substantially complete and on track to deliver first production by end of H1 2023.Caucharí-Olaroz expects to ramp up in H2 2023 and reach full production rate of 40,000 tonnes per annum (“tpa”) of lithium carbonate by Q1 2024. Commissioning of the solvent exchange and purification plants are underway with additional purification necessary to achieve battery-quality expected to be completed in H2 2023 following the start of pre-commercial production. Ponds and liming plant are fully operational.As of March 30, 2023, the Company...

PyroGenesis Announces 2022 Fourth Quarter and Year End Results

Written by Customer Service on March 31, 2023. Posted in Earnings Releases And Operating Results.

Solution Ecosystem Solution EcosystemMONTREAL, March 31, 2023 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (NASDAQ: PYR) (FRA: 8PY), a high-tech company (hereinafter referred to as the “Company” or “PyroGenesis”), that designs, develops, manufactures and commercializes advanced plasma processes and sustainable solutions which are geared to reduce greenhouse gases (GHG), is pleased to announce today its financial and operational results for the fourth quarter and the fiscal year ended December 31st, 2022. “The industrial decarbonization policy landscape continues to evolve in ways that we expect to benefit the long-term success of our company,” said Mr. P. Peter Pascali, President and CEO of PyroGenesis. “Forward leaning social sentiment has long been the major input driving public and corporate...

Ventricular Assist Device Market Size to Surpass USD 2.56 Billion by 2030, With 10.8% CAGR

Written by Customer Service on March 31, 2023. Posted in Mergers And Acquisitions.

According to Fortune Business Insights, The Global Ventricular Assist Device Market size is projected to reach USD 2.56 Billion by 2030, at a CAGR of 10.8% during the forecast period, 2023-2030 Pune, India, March 31, 2023 (GLOBE NEWSWIRE) — The global Ventricular Assist Device Market size hit USD 1.15 billion in 2022. The market valuation is expected to grow from USD 1.25 billion in 2023 to USD 2.56 Billion by 2030 at a 10.8% CAGR during the forecast period. Heart Failure (HF) prevalence has been rising noticeably all over the world. The prevalence of the disease is rising as a result of factors such as bad food and lifestyle changes, among others. According to a piece written by the AME Publishing Company, there were around 64.4 million cases of heart failure worldwide in 2020. 51% of the patients had severe heart failure, which...

Month: March 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice